ChristianaCare spins off start-up company using its gene editing technology

Delaware Business Now

Oct 11, 2022

ChristianaCare has spun out its first commercial biotechnology start-up, CorriXR Therapeutics with $5 million in seed funding CorriXR Therapeutics (pronounced Cor-ix-er; from Galic…